Acute disseminated encephalomyelitis future or investigational therapies: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(2 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Acute disseminated encephalomyelitis}}
{{Acute disseminated encephalomyelitis}}
{{CMG}}; {{AE}}
{{CMG}}; {{AE}} {{Sujaya}}
 
==Overview==
{{PleaseHelp}}
The use of emerging [[therapies]] has not been reported in patients with [[acute]] [[demyelinating]] [[diseases]] like [[ADEM]].
==Future or [[Investigational]] [[Therapies]]==
The use of emerging [[therapies]] has not been reported in patients with [[acute]] [[demyelinating]] [[diseases]] like [[ADEM]]<ref name="pmid22476745">{{cite journal| author=Pohl D, Tenembaum S| title=Treatment of acute disseminated encephalomyelitis. | journal=Curr Treat Options Neurol | year= 2012 | volume= 14 | issue= 3 | pages= 264-75 | pmid=22476745 | doi=10.1007/s11940-012-0170-0 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22476745  }} </ref>.


==Overview==


==Future or Investigational Therapies==


==References==
==References==
Line 13: Line 13:


[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Infectious disease]]
 
[[Category:Neurology]]
[[Category:Neurology]]


{{WS}}
{{WS}}
{{WH}}
{{WH}}

Latest revision as of 09:49, 22 November 2022

Acute disseminated encephalomyelitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Acute disseminated encephalomyelitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Acute disseminated encephalomyelitis future or investigational therapies On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Acute disseminated encephalomyelitis future or investigational therapies

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Acute disseminated encephalomyelitis future or investigational therapies

CDC on Acute disseminated encephalomyelitis future or investigational therapies

Acute disseminated encephalomyelitis future or investigational therapies in the news

Blogs on Acute disseminated encephalomyelitis future or investigational therapies

Directions to Hospitals Treating Acute disseminated encephalomyelitis

Risk calculators and risk factors for Acute disseminated encephalomyelitis future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sujaya Chattopadhyay, M.D.[2]

Overview

The use of emerging therapies has not been reported in patients with acute demyelinating diseases like ADEM.

Future or Investigational Therapies

The use of emerging therapies has not been reported in patients with acute demyelinating diseases like ADEM[1].


References

  1. Pohl D, Tenembaum S (2012). "Treatment of acute disseminated encephalomyelitis". Curr Treat Options Neurol. 14 (3): 264–75. doi:10.1007/s11940-012-0170-0. PMID 22476745.

Template:WS Template:WH